Literature DB >> 30076976

Developing a new antibiotic for extensively drug-resistant pathogens: the case of plazomicin.

U Theuretzbacher1, M Paul2.   

Abstract

Entities:  

Keywords:  Antibiotic; Clinical trial; Plazomicin; Resistance

Mesh：

Substances：

Year:  2018        PMID： 30076976     DOI： 10.1016/j.cmi.2018.07.020

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

1.  Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics.

Authors:  Martti Vaara
Journal:  Front Microbiol       Date:  2019-07-25       Impact factor: 5.640

Review 2.  The global preclinical antibacterial pipeline.

Authors:  Ursula Theuretzbacher; Kevin Outterson; Aleks Engel; Anders Karlén
Journal:  Nat Rev Microbiol       Date:  2019-11-19       Impact factor: 60.633

Review 3.  Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.

Authors:  Kathleen Tompkins; David van Duin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-06-24       Impact factor: 5.103

4.  Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.

Authors:  Jeffrey R Strich; Sarah Warner; Yi Ling Lai; Cumhur Y Demirkale; John H Powers; Robert L Danner; Sameer S Kadri
Journal:  Lancet Infect Dis       Date:  2020-06-04       Impact factor: 71.421
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.